← Toutes les offres
AA

Global Medical Manager Oncology - Biosimilars

Abbott AG

Allschwil, Bl
CDI
Publié le 17 novembre 2026 · Expire le 17 décembre 2026

Description du poste

--- base: meta-keywords: meta-viewport: width=device-width, initial-scale=1.0 title: Global Medical Manager Oncology - Biosimilars ---   Global Medical Manager Oncology - Biosimilars ============================================== Global Medical Manager Oncology – Biosimilars ---------------------------------------------------   Location: Basel, Switzerland | Division: Established Pharmaceuticals (EPD)   At Abbott, we believe people can live fuller lives through better health. Every day, our medicines and technologies help millions of people around the world manage health conditions, overcome barriers to care, and achieve better outcomes.   Biologics have transformed cancer care—and biosimilars are making this breakthrough accessible to more people worldwide. By delivering high-quality, affordable alternatives, biosimilars open the door to earlier treatment, reduce disease burden, and promote equity in healthcare.   About the Opportunity   Reporting to the Global Medical Director and working closely with the Oncology Biologics Core Team, this strategic global role is responsible for driving the medical affairs strategy across oncology biosimilar assets and multiple tumor indications. The position plays a key role in supporting global launches, evidence generation, scientific engagement, and medical excellence, with a particular focus on enabling success across Emerging Markets.   Main Responsibilities   Global Medical Strategy & Launch Leadership Owns the global medical strategy for assigned oncology biologics across multiple tumor indications Leads medical launch readiness and life cycle planning, with specific accountability for Emerging Market Serves as senior medical representative on global cross functional and brand teams   Scientific Leadership & Strategic Insight Acts as a global scientific leader for the portfolio, identifying unmet needs, data gaps, and long‑term medical opportunities Provides senior medical input into asset strategy, indication sequencing,